Dyax dyax.com


Public lists: Rare Diseases (230)

Dyax is focused on advancing novel biotherapeutics for unmet medical needs, with an emphasis on inflammatory and oncology indications. The Company utilizes its proprietary drug discovery technology to identify antibody, small protein and peptide compounds for clinical development. Dyax also leverages this technology broadly with over 70 revenue generating licenses and collaborations for therapeutic discovery, as well as in non-core areas such as affinity separations, diagnostic imaging, and rese...Show all

Dyax is focused on advancing novel biotherapeutics for unmet medical needs, with an emphasis on inflammatory and oncology indications. The Company utilizes its proprietary drug discovery technology to identify antibody, small protein and peptide comp...Show all

Company (Acquired)

Phone: 617-225-2500

Fax: 617-225-2501

55 Network Drive

Burlington, 01803
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Dyax $48.8M Jan 22, 2016
See all 25 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Dyax Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
Focus VenturesVenture CapitalPalo Alto, California, United StatesUnattributed VC
Alta PartnersVenture CapitalSan Francisco, California, United StatesUnattributed VC
Chase H&QUnattributed VC
GoldPoint PartnersPrivate EquityNew York, New York, United StatesUnattributed VC
BancBoston CapitalVenture CapitalBoston, Massachusetts, United StatesUnattributed VC
See all 12 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors
See all 25 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Libraries of genetic packages comprising novel hc cdr3 designs Mar 13, 2009 Jan 23, 2018 Patent
Methods of producing antibodies to neonatal fc receptor (fcrn) Apr 27, 2016 Jan 09, 2018 Patent
Peptides that specifically bind hgf receptor (cmet) and uses thereof Feb 19, 2015 Dec 19, 2017 Patent
Focused libraries of genetic packages Jan 30, 2013 Oct 31, 2017 Patent
Antibodies against phosphorylcholine Aug 08, 2012 Oct 31, 2017 Patent
See all 126 patents